Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Cash from Financing Activities (2018 - 2025)

KalVista Pharmaceuticals' Cash from Financing Activities history spans 8 years, with the latest figure at $4.7 million for Q2 2025.

  • On a quarterly basis, Cash from Financing Activities fell 96.9% to $4.7 million in Q2 2025 year-over-year; TTM through Apr 2025 was $158.1 million, a 4.87% increase, with the full-year FY2025 number at $159.7 million, up 5.98% from a year prior.
  • Cash from Financing Activities hit $4.7 million in Q2 2025 for KalVista Pharmaceuticals, up from $295000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for KALV hit a ceiling of $150.1 million in Q2 2024 and a floor of $128000.0 in Q4 2023.
  • Historically, Cash from Financing Activities has averaged $22.7 million across 3 years, with a median of $295000.0 in 2024.
  • Biggest five-year swings in Cash from Financing Activities: surged 1370.59% in 2024 and later plummeted 96.9% in 2025.
  • Tracing KALV's Cash from Financing Activities over 3 years: stood at $128000.0 in 2023, then skyrocketed by 130.47% to $295000.0 in 2024, then soared by 1479.32% to $4.7 million in 2025.
  • Business Quant data shows Cash from Financing Activities for KALV at $4.7 million in Q2 2025, $295000.0 in Q4 2024, and $3.0 million in Q3 2024.